Literature DB >> 17430303

Specificity of mood stabilizer action on neuronal growth cones.

Galit Shaltiel1, Emma C Dalton, Robert H Belmaker, Adrian J Harwood, Galila Agam.   

Abstract

OBJECTIVES: Lithium, valproic acid (VPA) and carbamazepine (CBZ) are commonly used mood stabilizers, but their therapeutic mechanism is unclear. These drugs all cause the same morphological effects on postnatal rat neuronal dorsal root ganglia (DRG) growth cones via an inositol-reversible mechanism. However, due to limitations in earlier analysis, the effects of combining drugs, drug specificity and inositol stereoisomer specificity are unknown. We devised an improved analytical method to address these issues.
METHODS: Dorsal root ganglia explants were cultured individually and incubated with combinations of psychotropic drugs and inositol stereoisomers. We recorded axonal growth cone morphology and calculated growth cone area per a modified method described by Williams et al. (Nature 2002; 417: 292-295). Statistically significant changes in area were calculated using non-parametric statistical testing.
RESULTS: (i) Lithium and VPA showed an additive effect on growth cone spreading. (ii) Among eight additional psychotropic drugs to those previously tested, only imipramine and chlorpromazine altered DRG growth cone morphology. As this effect was not reversed by myo-inositol, it arises from a different mechanism to the mood stabilizers lithium, VPA and CBZ. (iii) Myo-inositol, but not scyllo- or epi-inositol, causes a significant reversal of the lithium effect on the growth cones spreading, consistent with the inositol depletion hypothesis.
CONCLUSIONS: These results show that lithium, VPA and CBZ are unique in causing altered neuronal morphology via myo-inositol depletion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430303     DOI: 10.1111/j.1399-5618.2007.00400.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  6 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

Review 2.  Peripheral Somatosensory Neuron Dysfunction: Emerging Roles in Autism Spectrum Disorders.

Authors:  Lauren L Orefice
Journal:  Neuroscience       Date:  2020-02-06       Impact factor: 3.590

3.  A second-generation Bacillus cell factory for rare inositol production.

Authors:  Kosei Tanaka; Shinji Takanaka; Ken-ichi Yoshida
Journal:  Bioengineered       Date:  2014 Sep-Oct       Impact factor: 3.269

Review 4.  Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.

Authors:  Dan Song; Baoman Li; Enzhi Yan; Yi Man; Marina Wolfson; Ye Chen; Liang Peng
Journal:  Neurochem Res       Date:  2012-07-28       Impact factor: 3.996

5.  A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.

Authors:  Kelly M McVearry; William D Gaillard; John VanMeter; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2009-11-04       Impact factor: 2.937

6.  The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.

Authors:  Pishan Chang; Benoit Orabi; Rania M Deranieh; Manik Dham; Oliver Hoeller; Jakob A Shimshoni; Boris Yagen; Meir Bialer; Miriam L Greenberg; Matthew C Walker; Robin S B Williams
Journal:  Dis Model Mech       Date:  2011-08-29       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.